Advertisement
Screener

PAYCOR HCM, INC. Spending and interest coverage

PAYCOR HCM, INC. Spending and interest coverage

  • R&D / revenue · 12 months: Value 10.33%; Formula and calculation Research and development expense / revenue. Period ending 2024-12-31..
  • Stock-based compensation / revenue · 12 months: Value 9.05%; Formula and calculation Share-based compensation / revenue. Period ending 2024-12-31..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2024-12-31; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months10.33%Research and development expense / revenue. Period ending 2024-12-31.

$66.50M ÷ $643.83M × 100 ≈ 10.33%

Stock-based compensation / revenue · 12 months9.05%Share-based compensation / revenue. Period ending 2024-12-31.

$58.28M ÷ $643.83M × 100 ≈ 9.05%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending66.50M USDResearch and Development Expense
Revenue643.83M USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation58.28M USDShare-based Payment Arrangement, Noncash Expense
Operating income-18.97M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2024-12-31$66.50M$643.83M$58.28M$-18.97M(m)10.33%9.05%(m)(m)
2024-09-30$64.79M$623.68M$65.19M$-46.33M(m)10.39%10.45%(m)(m)
2024-06-30$61.42M$602.39M$65.44M$-55.45M(m)10.20%10.86%(m)(m)
2024-03-31(m)(m)(m)(m)$4.72M(m)(m)(m)Reported
2023-12-31(m)(m)(m)(m)$5.54M(m)(m)(m)Reported
2023-09-30(m)(m)(m)(m)$4.79M(m)(m)(m)Reported
2023-06-30(m)(m)(m)(m)$4.64M(m)(m)(m)Reported
2023-03-31(m)(m)(m)(m)$3.55M(m)(m)(m)Reported
2022-12-31(m)(m)(m)(m)$1.69M(m)(m)(m)Reported
2022-09-30(m)(m)(m)(m)$1.39M(m)(m)(m)Reported
2022-06-30(m)(m)(m)(m)$541.00K(m)(m)(m)Reported
2022-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30$36.02M$350.96M$4.17M$-89.33M$2.54M10.26%1.19%-35.16×Reported
2021-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30$45.87M$317.62M$4.91M$-94.71M$1.78M14.44%1.54%-53.21×Reported
2019-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-11-01(m)(m)(m)(m)(m)(m)(m)(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.